1. Home
  2. NTWK vs FEMY Comparison

NTWK vs FEMY Comparison

Compare NTWK & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$3.33

Market Cap

38.0M

Sector

Technology

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.54

Market Cap

37.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTWK
FEMY
Founded
1997
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0M
37.2M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
NTWK
FEMY
Price
$3.33
$0.54
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.83
AVG Volume (30 Days)
51.8K
523.5K
Earning Date
05-22-2026
02-28-2026
Dividend Yield
N/A
N/A
EPS Growth
316.67
8.60
EPS
N/A
N/A
Revenue
$73,088,687.00
$1,629,108.00
Revenue This Year
N/A
$64.02
Revenue Next Year
N/A
$147.19
P/E Ratio
N/A
N/A
Revenue Growth
13.40
51.97
52 Week Low
$2.14
$0.31
52 Week High
$5.75
$1.76

Technical Indicators

Market Signals
Indicator
NTWK
FEMY
Relative Strength Index (RSI) 52.38 44.74
Support Level $3.06 $0.47
Resistance Level $3.45 $0.55
Average True Range (ATR) 0.34 0.04
MACD -0.00 0.01
Stochastic Oscillator 28.18 66.96

Price Performance

Historical Comparison
NTWK
FEMY

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: